Silver Grove Financial Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95K Buy
+65
New +$1.84K ﹤0.01% 1619

Other funds holding LKFT

Silver Grove Financial Group's LKFT Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 65 shares worth $1.95K. The stake represents ﹤0.01% of the portfolio and ranks #1619 among its holdings.

77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Silver Grove Financial Group held 65 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.95K as of Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Silver Grove Financial Group position in Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #1619 holding.
  • 77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.